Table 1.

Summary information for each randomized controlled trial or effectiveness study in the Maternal BEP Studies Harmonization Initiative

Full study name	Short name	Country	Study design	Life stages receiving BEP	Enrollment @ life stage	Registry	Principal Investigators
Enhancing Nutrition and Antenatal Infection Treatment for Maternal and Child Health	ENAT	Ethiopia	Cluster (health center) and individual (within health center) randomizationa	Pregnancy	~ 2400 @ < 24 weeks gestation	ISRCTN registry ISRCTN15116516	Anne CC Lee; Yemane Berhane
IMPRINTb	IMPRINT	India	Individual randomization	Lactation	816 @  < 1 week after delivery	Clinical Trials Registry-India CTRI/2018/04/013095	Sunita Taneja
Mothers and Infants Nutrition Trial	MINT	Nepal	Individual randomization	Pregnancy	900 @ early pregnancy	ClinicalTrials.gov NCT03668977	James Tielsch
MIcronutriments pour la SAnté de la Mère et de l’Enfant III	MISAME-III	Burkina Faso	Individual randomization with factorial designc	Pregnancy Lactation	1788 @ early pregnancy	ClinicalTrials.gov NCT03533712	Patrick Kolsteren
Mumta Pregnant Women Trial	MumtaPW	Pakistan	Individual randomization	Pregnancy	1836 @ pregnancy	ClinicalTrials.gov NCT04012177	Yasir Shafiq; Ameer Muhammad
Mumta Lactating Women Trial	MumtaLW	Pakistan	Individual randomization	Lactation	957 @  < 1 week after delivery	ClinicalTrials.gov NCT03564652	Yasir Shafiq; Ameer Muhammad
Women and Infants Integrated Interventions for Growth Study	WINGS	India	Individual randomization with factorial designc	Preconception Pregnancy Lactation	13,500 @ preconception	Clinical Trials Registry-India CTRI/2017/06/008908	Nita Bhandari

BEP balanced energy-protein

^aPragmatic clinical effectiveness study

^bAdded to Harmonization Initiative in October 2020

^cFactorial design for MISAME-III was random assignment for pregnancy and random assignment for postpartum; factorial design for WINGS was random assignment for preconception and random assignment for pregnancy (women were also stratified by height at enrollment)